Show simple item record

dc.contributor.author
Borrell, Sònia
dc.contributor.author
Trauner, Andrej
dc.contributor.author
Brites, Daniela
dc.contributor.author
Rigouts, Leen
dc.contributor.author
Loiseau, Chloe
dc.contributor.author
Coscolla, Mireia
dc.contributor.author
Niemann, Stefan
dc.contributor.author
De Jong, Bouke
dc.contributor.author
Yeboah-Manu, Dorothy
dc.contributor.author
Kato-Maeda, Midori
dc.contributor.author
Feldmann, Julia
dc.contributor.author
Reinhardt, Miriam
dc.contributor.author
Beisel, Christian
dc.contributor.author
Gagneux, Sebastien
dc.date.accessioned
2019-04-05T08:06:12Z
dc.date.available
2019-04-05T01:31:36Z
dc.date.available
2019-04-05T08:06:12Z
dc.date.issued
2019
dc.identifier.issn
1932-6203
dc.identifier.other
10.1371/journal.pone.0214088
en_US
dc.identifier.uri
http://hdl.handle.net/20.500.11850/336262
dc.identifier.doi
10.3929/ethz-b-000336262
dc.description.abstract
The Mycobacterium tuberculosis complex (MTBC) causes tuberculosis (TB) in humans and various other mammals. The human-adapted members of the MTBC comprise seven phylogenetic lineages that differ in their geographical distribution. There is growing evidence that this phylogeographic diversity modulates the outcome of TB infection and disease. For decades, TB research and development has focused on the two canonical MTBC laboratory strains H37Rv and Erdman, both of which belong to Lineage 4. Relying on only a few laboratory-adapted strains can be misleading as study results might not be directly transferrable to clinical settings where patients are infected with a diverse array of strains, including drug-resistant variants. Here, we argue for the need to expand TB research and development by incorporating the phylogenetic diversity of the MTBC. To facilitate such work, we have assembled a group of 20 genetically well-characterized clinical strains representing the seven known human-adapted MTBC lineages. With the “MTBC clinical strains reference set” we aim to provide a standardized resource for the TB community. We hope it will enable more direct comparisons between studies that explore the physiology of MTBC beyond the laboratory strains used thus far. We anticipate that detailed phenotypic analyses of this reference strain set will increase our understanding of TB biology and assist in the development of new control tools that are broadly effective.
en_US
dc.format
application/pdf
en_US
dc.language.iso
en
en_US
dc.publisher
PLOS
dc.rights.uri
http://creativecommons.org/licenses/by/4.0/
dc.title
Reference set of Mycobacterium tuberculosis clinical strains: A tool for research and product development
en_US
dc.type
Journal Article
dc.rights.license
Creative Commons Attribution 4.0 International
dc.date.published
2019-03-25
ethz.journal.title
PLoS ONE
ethz.journal.volume
14
en_US
ethz.journal.issue
3
en_US
ethz.journal.abbreviated
PLoS ONE
ethz.pages.start
e0214088
en_US
ethz.size
12 p.
en_US
ethz.version.deposit
publishedVersion
en_US
ethz.identifier.wos
ethz.identifier.scopus
ethz.publication.place
San Francisco, CA
ethz.publication.status
published
en_US
ethz.date.deposited
2019-04-05T01:31:37Z
ethz.source
SCOPUS
ethz.eth
yes
en_US
ethz.availability
Open access
en_US
ethz.rosetta.installDate
2019-04-05T08:06:28Z
ethz.rosetta.lastUpdated
2024-02-02T07:34:52Z
ethz.rosetta.versionExported
true
ethz.COinS
ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.atitle=Reference%20set%20of%20Mycobacterium%20tuberculosis%20clinical%20strains:%20A%20tool%20for%20research%20and%20product%20development&rft.jtitle=PLoS%20ONE&rft.date=2019&rft.volume=14&rft.issue=3&rft.spage=e0214088&rft.issn=1932-6203&rft.au=Borrell,%20S%C3%B2nia&Trauner,%20Andrej&Brites,%20Daniela&Rigouts,%20Leen&Loiseau,%20Chloe&rft.genre=article&rft_id=info:doi/10.1371/journal.pone.0214088&
 Search print copy at ETH Library

Files in this item

Thumbnail

Publication type

Show simple item record